Glenmark and Cediprof announce exclusive distribution agreement in US

Glenmark Pharmaceuticals on Thursday said it has entered into an exclusive agreement with Cediprof Inc for supply and distribution in the US for the latter's generic drug indicated for the treatment of attention deficit hyperactivity disorder.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GKOMw4L
via IFTTT